| Product Code: ETC7916965 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Latvia continued to heavily rely on imports of octreotide, with significant shipments coming from key exporting countries such as India, Germany, China, USA, and Lithuania. The high Herfindahl-Hirschman Index (HHI) indicates a concentrated market. The impressive compound annual growth rate (CAGR) of 50.33% from 2020 to 2024 highlights the increasing demand for octreotide in Latvia. Moreover, the growth rate of 39.93% from 2023 to 2024 suggests sustained momentum in the market. This data underscores the importance of these import shipments in meeting the country`s octreotide needs.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Latvia Octreotide Market Overview |
3.1 Latvia Country Macro Economic Indicators |
3.2 Latvia Octreotide Market Revenues & Volume, 2021 & 2031F |
3.3 Latvia Octreotide Market - Industry Life Cycle |
3.4 Latvia Octreotide Market - Porter's Five Forces |
3.5 Latvia Octreotide Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Latvia Octreotide Market Revenues & Volume Share, By Form, 2021 & 2031F |
3.7 Latvia Octreotide Market Revenues & Volume Share, By Indications, 2021 & 2031F |
3.8 Latvia Octreotide Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 Latvia Octreotide Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Latvia Octreotide Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of hormonal disorders and neuroendocrine tumors in Latvia |
4.2.2 Growing awareness and adoption of advanced medical treatments |
4.2.3 Rise in healthcare expenditure and infrastructure development in the country |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval and commercialization of pharmaceutical products |
4.3.2 Limited availability of skilled healthcare professionals specialized in treating hormonal disorders |
4.3.3 High cost associated with octreotide therapy leading to affordability issues for patients |
5 Latvia Octreotide Market Trends |
6 Latvia Octreotide Market, By Types |
6.1 Latvia Octreotide Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Latvia Octreotide Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Latvia Octreotide Market Revenues & Volume, By octreotide acetate, 2021- 2031F |
6.1.4 Latvia Octreotide Market Revenues & Volume, By octreotide, 2021- 2031F |
6.1.5 Latvia Octreotide Market Revenues & Volume, By octreotide chloride, 2021- 2031F |
6.1.6 Latvia Octreotide Market Revenues & Volume, By octreotide hydrochloride, 2021- 2031F |
6.1.7 Latvia Octreotide Market Revenues & Volume, By indium In-111; octreotide, 2021- 2031F |
6.2 Latvia Octreotide Market, By Form |
6.2.1 Overview and Analysis |
6.2.2 Latvia Octreotide Market Revenues & Volume, By Injection, 2021- 2031F |
6.2.3 Latvia Octreotide Market Revenues & Volume, By Powder, 2021- 2031F |
6.2.4 Latvia Octreotide Market Revenues & Volume, By Microspheres, 2021- 2031F |
6.3 Latvia Octreotide Market, By Indications |
6.3.1 Overview and Analysis |
6.3.2 Latvia Octreotide Market Revenues & Volume, By Diarrhoea, 2021- 2031F |
6.3.3 Latvia Octreotide Market Revenues & Volume, By Acromegaly, 2021- 2031F |
6.3.4 Latvia Octreotide Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Latvia Octreotide Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Latvia Octreotide Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Latvia Octreotide Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.4 Latvia Octreotide Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.5 Latvia Octreotide Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Latvia Octreotide Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Latvia Octreotide Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 Latvia Octreotide Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.5.4 Latvia Octreotide Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 Latvia Octreotide Market Import-Export Trade Statistics |
7.1 Latvia Octreotide Market Export to Major Countries |
7.2 Latvia Octreotide Market Imports from Major Countries |
8 Latvia Octreotide Market Key Performance Indicators |
8.1 Patient population growth rate for hormonal disorders in Latvia |
8.2 Number of healthcare facilities offering octreotide therapy |
8.3 Adoption rate of octreotide treatment guidelines by healthcare providers |
8.4 Rate of reimbursement for octreotide therapy by healthcare payers |
9 Latvia Octreotide Market - Opportunity Assessment |
9.1 Latvia Octreotide Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Latvia Octreotide Market Opportunity Assessment, By Form, 2021 & 2031F |
9.3 Latvia Octreotide Market Opportunity Assessment, By Indications, 2021 & 2031F |
9.4 Latvia Octreotide Market Opportunity Assessment, By End User, 2021 & 2031F |
9.5 Latvia Octreotide Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Latvia Octreotide Market - Competitive Landscape |
10.1 Latvia Octreotide Market Revenue Share, By Companies, 2024 |
10.2 Latvia Octreotide Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here